COST-EFFECTIVENESS ANALYSIS OF A MULTIDISCIPLINARY SUPPORT PROGRAM IN HEPATITIS C TREATMENT

被引：0

作者：

Garcia-Retortillo, Montserrat ^{[1
]}

Cirera, Isabel ^{[1
]}

Dolors Gimenez, M. ^{[1
]}

Marquez, Carmen ^{[1
]}

Canete, Nuria ^{[1
]}

Carrion, Jose A. ^{[1
]}

Castellvi, Pere ^{[1
]}

Lazaro, Diego ^{[1
]}

Navines, Ricard ^{[2
,3
,4
]}

Castano, Juan R. ^{[5
]}

Urbina, Olatz ^{[6
]}

Salas, Esther ^{[6
]}

Bory, Felip ^{[1
]}

Martin-Santos, Rocio ^{[2
,3
,4
]}

Rubio-Terres, Carlos ^{[7
]}

Martin-Escudero, Victoria ^{[8
]}

Sola, Ricard ^{[1
]}

机构：

[1] Univ Autonoma Barcelona, Liver Sect, Hosp del Mar, IMIM, E-08193 Barcelona, Spain

[2] Univ Barcelona, Inst Neurosci, Dept Psychiat, IDIBAPS,Hosp Clin, Barcelona, Spain

[3] Univ Barcelona, Inst Neurosci, Dept Psychol, IDIBAPS,Hosp Clin, Barcelona, Spain

[4] Hosp del Mar, IMIM, Neuropsychopharmacol Programme, Barcelona, Spain

[5] Hosp del Mar, IMIM, Dept Psychiat, Barcelona, Spain

[6] Hosp del Mar, Dept Pharm, Barcelona, Spain

[7] Hlth Value, Madrid, Spain

[8] Roche Farma, Madrid, Spain

来源：

HEPATOLOGY | 2011年 / 54卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：800A / 801A

页数：2

共 50 条

[31] COST-EFFECTIVENESS ANALYSIS OF DACLATASVIR WITH ASUNAPREVIR IN TREATMENT OF CHRONIC HEPATITIS C IN THE RUSSIAN FEDERATION
Yagudina, R.
Kulikov, A.
Babiy, V. V.
VALUE IN HEALTH, 2016, 19 (07) : A415 - A415
[32] The cost-effectiveness of screening and treatment for hepatitis C in prisons in England and Wales: a cost-utility analysis
Sutton, A. J.
Edmunds, W. J.
Sweeting, M. J.
Gill, O. N.
JOURNAL OF VIRAL HEPATITIS, 2008, 15 (11) : 797 - 808
[33] Cost-effectiveness analysis of lamivudine for the treatment of chronic hepatitis B
Crowley, SJ
Tognarini, D
Desmond, PV
Lees, M
PHARMACOECONOMICS, 2000, 17 (05) : 409 - 427
[34] Cost-Effectiveness Analysis of Lamivudine for the Treatment of Chronic Hepatitis B
Steven J. Crowley
David Tognarini
Paul V. Desmond
Michael Lees
PharmacoEconomics, 2000, 17 : 409 - 427
[35] Treatment alternatives for hepatitis B cirrhosis: A cost-effectiveness analysis
Kanwal, Fasiha
Farid, Mary
Martin, Paul
Chen, Gary
Gralnek, Ian M.
Dulai, Gareth S.
Spiegel, Brennan M. R.
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : 2076 - 2089
[36] Treatment alternatives for hepatitis B cirrhosis: A cost-effectiveness analysis
Kanwal, F
Farid, M
Martin, P
Chen, G
Gralnek, IM
Dulai, GS
Spiegel, BM
HEPATOLOGY, 2005, 42 (04) : 351A - 351A
[37] The cost of hepatitis C and the cost-effectiveness of its prevention
Shiell, A
Law, MG
HEALTH POLICY, 2001, 58 (02) : 121 - 131
[38] Safety, efficiency, and cost-effectiveness of a multidisciplinary percutaneous tracheostomy program
Mirski, Marek A.
Pandian, Vinciya
Bhatti, Nasir
Haut, Elliott
Feller-Kopman, David
Morad, Athir
Haider, Adil
Schiavi, Adam
Efron, David
Ulatowski, John
CRITICAL CARE MEDICINE, 2012, 40 (06) : 1827 - 1834
[39] A TREATMENT PROGRAM FOR FAILURE-TO-THRIVE - A COST-EFFECTIVENESS ANALYSIS
KARNISKI, W
VANBUREN, L
CUPOLI, JM
CHILD ABUSE & NEGLECT, 1986, 10 (04) : 471 - 478
[40] Cost-effectiveness of increased screening and treatment of chronic hepatitis C in Korea
Kim, Do Young
Wong, Gabriel
Lee, Janet
Kim, Myung Hwa
Smith, Nathaniel
Blissett, Rob
Kim, Hyung Joon
CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (06) : 993 - 1002

← 1 2 3 4 5 →